# \[e-drug\] Same tablet and company but different name (3)

**URL:** <https://talk.edrugplus.org/t/e-drug-same-tablet-and-company-but-different-name-3/18779>\
**Category:** e-drug\
**Created:** [February 4, 2004, 12:09am UTC](https://talk.edrugplus.org/t/e-drug-same-tablet-and-company-but-different-name-3/18779 "2004-02-04T00:09:25Z")\
**Posts on this page:** 1\
**Page:** 1

<div class="post-metadata">

**Author:** ![valeria.frighi1](https://avatars.discourse-cdn.com/v4/letter/v/87869e/32.png) [@valeria.frighi1](https://talk.edrugplus.org/u/valeria.frighi1)\
**Post date:** [February 4, 2004, 12:09am UTC](https://talk.edrugplus.org/t/e-drug-same-tablet-and-company-but-different-name-3/18779/1 "2004-02-04T00:09:25Z")

</div>

E-DRUG: Same tablet and company but different name (3)  
--------------------------------------------

> If prescribers make it a habit to prescribe exclusively by generic names,

such

> marketing tricks would be completely irrelevant, and the industry might

stop

> playing these consumer hostile tricks too.  
> Thus, what the EU could do about this would be encouraging their doctors

to

> prescribe by generic name.

My reply doesn't have a lot to do with the issue of reimporting but it  
might be of general interest to see how health services can end up  
paying for drugs much more than they should.

In the UK, contrary to what happens in several other European countries,  
we ALWAYS prescribe by the pharmacological name of the drug, which is  
the name retained when the this becomes a generic.

However, the problem arises at dispensing level as pharmacists are not  
bound to prescribe the cheapest drug with that particular  
pharmacological compound. More often than not what is dispensed to the  
patient is a "branded generic". The difference in price between a "true  
generic" and a branded one is generally small (even when the branded  
generic costs 2 or 3 times as  
much), but often the difference is not so small. At any rate, given the  
volume of prescription only drugs, this freedom of choice at dispensing  
level  
must cost the National Health Service million of pounds every year.

It is also interesting to see that branded generics always come in  
flashy boxes, with "health-problem related", intuitive names contrary to  
the plain boxes and the difficult to pronounce pharmacological names of  
true generics. This is not a big deal in wealthy countries as consumers  
are generally well off, but if the same applies to developing countries,  
I guess it will be much more serious.

Valeria

Dr Valeria Frighi  
Oxford Centre for Diabetes, Endocrinology and Metabolism  
Churchill Hospital  
Oxford  
UK  
valeria.frighi@dtu.ox.ac.uk

--  
To send a message to E-Drug, write to: e-drug@healthnet.org  
To subscribe or unsubscribe, write to: majordomo@healthnet.org  
in the body of the message type: subscribe e-drug OR unsubscribe e-drug  
To contact a person, send a message to: e-drug-help@healthnet.org  
Information and archives: [Essentialdrugs.org](http://www.essentialdrugs.org/edrug)
